Albemarle Price Target Raised to $257; Strong Buy Consensus at 1.96
ALB•RBC Capital reiterated an Outperform rating for Albemarle and raised its price target from $253 to $257, reinforcing a broker consensus recommendation of 1.96 (Strong Buy). The company ranks among four diversified chemical firms set to benefit from a lithium demand rebound driven by electric vehicles and data centers.
1. Analyst Rating Revisions
RBC Capital reiterated its Outperform rating for Albemarle on May 26, 2026, and increased its price target from $253 to $257, signaling heightened confidence in the company’s growth trajectory.
2. Broker Consensus and Share Movement
The average brokerage recommendation for Albemarle stands at 1.96 (Strong Buy) based on 25 firms, even as shares have fallen 8.9% over the past month.
3. Industry Demand Rebound Outlook
Albemarle is identified among four diversified chemical companies poised to benefit from a rebound in lithium demand driven by electric vehicle adoption and expanding data center infrastructure.
